ISL
OGN icon

Ingalls & Snyder LLC’s Organon & Co OGN Stock Holding History

Ingalls & Snyder LLC’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,073
Closed -$272K – 450
2022
Q2 		$272K Sell
8,073
-1,447
-15% -$50.7K 0.01% 362
2022
Q1 		$333K Sell
9,520
-1,139
-11% -$39K 0.01% 354
2021
Q4 		$325K Sell
10,659
-3,131
-23% -$102K 0.01% 367
2021
Q3 		$452K Sell
13,790
-16,768
-55% -$537K 0.02% 319
2021
Q2 		$925K Buy
+30,558
New +$1.01M 0.04% 248

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ingalls & Snyder LLC's OGN Position: Q3 2022 in Review

Ingalls & Snyder LLC sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 8,073 shares — an estimated $272K sold.

Ingalls & Snyder LLC first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $925K in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Ingalls & Snyder LLC reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 8,073 Organon & Co shares in Q3 2022, an estimated $272K.
  • Ingalls & Snyder LLC first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Ingalls & Snyder LLC's Organon & Co position peaked at $925K in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Ingalls & Snyder LLC's 13F filing for Q3 2022, filed 21 Oct 2022.